Meng Wen, Zhu Hong-Hong, Li Hu, Wang Guoqing, Wei Dongshan, Feng Xing
Department of Public Health, College of Health and Human Service, Western Kentucky University, Bowling Green, KY 42101, USA.
BMC Res Notes. 2014 Aug 11;7:515. doi: 10.1186/1756-0500-7-515.
No case of solitary fibrous tumor of the pleura with Doege-Potter syndrome has been reported in China. This study was to report a rare repeatedly recurrent case of solitary fibrous tumor of the pleura with Doege-Potter syndrome diagnosed in China and a three-decade literature review of solitary fibrous tumor of the pleura with Doege-Potter syndrome worldwide.
A rare case of solitary fibrous tumor of the pleura with Doege-Potter syndrome was diagnosed in 2005 with follow-up to 2011. All medical records were collected and literature of solitary fibrous tumor of the pleura with Doege-Potter syndrome from 1979 to 2011 was obtained through Medline. This typical case, diagnosed and confirmed by histopathologic results, was a 72-year-old Chinese woman who had a complaint of night sweat for a month. A localized mass 12 cm × 11 cm × 8 cm in size was found associated with pleural effusion in her left low chest cavity, and blood tests showed severe hypoglycemia. Removal of the mass solved the hypoglycemia. The case was repeatedly recurrent in April, 2010 and March, 2011 and had no signs of recurrence up to the end of 2011 after surgery. A review of 45 cases of solitary fibrous tumor of the pleura with Doege-Potter syndrome compared and summarized clinical characteristics, treatments, and outcomes by benign and malignant tumor nature.
Incidence of solitary fibrous tumor of the pleura with Doege-Potter syndrome is similar between genders. There are no significant differences in clinical characteristics between benign and malignant cases. Surgery is the first effective treatment for solitary fibrous tumor of the pleura with Doege-Potter syndrome and the completeness of the initial resection is the key to preventing recurrence. Routine follow-up examinations are recommended for early detection of recurrence.
中国尚未有胸膜孤立性纤维瘤伴多伊格-波特综合征的病例报道。本研究旨在报告1例在中国诊断出的胸膜孤立性纤维瘤伴多伊格-波特综合征的罕见复发病例,并对全球范围内胸膜孤立性纤维瘤伴多伊格-波特综合征进行三十年的文献综述。
2005年诊断出1例罕见的胸膜孤立性纤维瘤伴多伊格-波特综合征病例,随访至2011年。收集了所有病历,并通过医学在线数据库(Medline)获取了1979年至2011年胸膜孤立性纤维瘤伴多伊格-波特综合征的文献。该典型病例经组织病理学结果诊断和证实,是一名72岁的中国女性,主诉盗汗1个月。在其左胸腔下部发现一个大小为12 cm×11 cm×8 cm的局限性肿块,伴有胸腔积液,血液检查显示严重低血糖。切除肿块后低血糖症状得以缓解。该病例在2010年4月和2011年3月反复复发,术后至2011年底无复发迹象。对45例胸膜孤立性纤维瘤伴多伊格-波特综合征病例进行回顾,按肿瘤的良恶性性质比较并总结了临床特征、治疗方法及预后。
胸膜孤立性纤维瘤伴多伊格-波特综合征的发病率在性别上相似。良性和恶性病例的临床特征无显著差异。手术是胸膜孤立性纤维瘤伴多伊格-波特综合征的首选有效治疗方法,初次切除的完整性是预防复发的关键。建议进行定期随访检查以早期发现复发。